Academic & Industry Intersection Conference: Georgia as a Biotechnology Capital?
Thursday, April 14, 2016
What is the purpose?
The Atlanta Clinical & Translational Science Institute (ACTSI), led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state's life sciences industry association, organizes this conference annually to provide critical information on how academia and industry can work together to translate science into discovery and engage communities in clinical research efforts and outcomes. The event provides a collaborative environment for university investigators and industry executives using a program filled with subject matter experts describing current models and innovative trends shaping the future of translational science.
What will be discussed?
The Seventh Annual Academic & Industry Intersection Conference will explore Georgia’s biotechnology climate, venture capital innovation, and feature an expert panel highlighting commercialization training options throughout the state.
C. Michael Cassidy, President & CEO, Georgia Research Alliance (GRA)
Cassidy will provide a local state-of-affairs on Georgia’s biotechnology past, present, and future to begin open dialogue and motivate change. As the leader of GRA for 16 years, he will deliver clear insight on the state’s journey as a biotechnology capital. While sharing his vision for the state, celebrating our strengths, and defining our weaknesses. His experience and understanding of city and state politics will resonate and enlighten the expert audience.
Kenneth I. Moch, Managing Partner, Salutramed Group
Moch will offer a regional and national perspective and discuss the current and future biotechnology climate. He will share best practices and advice for Georgia to become a biotechnology capital using his broad expertise building, managing, and financing private and public life sciences companies from start-up through commercialization, and creation of five companies which have pioneered novel technologies.
PANEL: Entrepreneurial Training Programs in Georgia
Moderator: Jack Tillman, Associate Vice President for Corporate Development, Emory University
- Pamela Bhatti, PhD, Associate Professor, Bioengineering Digital Signal Processing, School of Electrical and Computer Engineering, I-Corps, Georgia Institute of Technology
- Charles Goetz, Senior Lecturer in Organization and Management and Distinguished Lecturer Entrepreneurship, Goizueta Business School, Emory University
- James Lillard, PhD, MBA, Associate Dean for Research, Morehouse School of Medicine
- Nicole Morris, JD, Director of TI:GER (Technological Innovation: Generating Economic Results) and Professor in Practice, School of Law, Emory University
- Bob Pinckney, Director of Entrepreneurship Program and Lecturer, Terry College of Business, University of Georgia
PANEL: Local and National Investor Perspective
Moderator: Tiffany Wilson, Executive Director, Global Center for Medical Innovation (GCMI)
- Rachael Hagan, Director, Coulter Translational Program, Emory University and Georgia Institute of Technology
- Howard Palefsky, Director and Investor, Victoria Capital Management
- Rifat Pamukcu, MD, Chairman, President and Chief Executive Officer, Midway Pharmaceuticals, Inc.
ACTSI (Emory, MSM, GA Tech faculty & staff) $20
GaBio Members $30 (View our member directory to see if your company is a member.)
ONSITE REGISTRATION IS AVAILABLE. Online registration will close on April 12th at midnight. After that date, please register onsite. We take checks or credit cards onsite.
All cancellation requests must be made to firstname.lastname@example.org / 404-221-0617 within 5 days of the event to receive a refund.